Last Close
1,661.00 $
Jul 7, 26
Market Cap
4.9 B $
Q2 2025 (TTM)
52-Week Range
%-12.4
%33.7
-1.40
-1.21
%-14.5
-%40.4
1M
+12.9%
3M
+29.2%
6M
+7.8%
YTD
+10.3%
1Y
-12.4%
3Y
-0.5%
Returns are computed from split-adjusted closes; dividends are not included.
Stock and gold/silver returns are in USD (metals converted into the stock's currency). The FTSE 100 index is measured in its own currency.
HIK last closed at 1,661.00 $ (Jul 7, 26). Price data is refreshed after every trading day.
Hikma Pharmaceuticals PLC trades at a trailing-twelve-month P/E of 12.27. See the comparison tables on the Peers tab for the industry context.
Hikma Pharmaceuticals PLC (HIK) has a market capitalization of approximately 4.9 B $ as of the latest reported period.
Key peers of Hikma Pharmaceuticals PLC include Turk Ilac Ve Serum Sanayi Anonim Sirketi, Assertio Therapeutics Inc, Anika Therapeutics Inc, BioXcel Therapeutics Inc, SIGA Technologies Inc. A detailed metric comparison is available on the Peers tab.
Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.